Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model

Frontiers in Pharmacology(2023)10.3389/fphar.2023.1294579Source: DataRank Database

Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model is a research paper published in Frontiers in Pharmacology (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.92)OA: goldTopics (28)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Brady Sillman ORCID,Yutong Liu ORCID,Micah Summerlin,Vikas Kumar ORCID,Balasrinivasa R. Sajja

Live enrichment

PubMed:38149054 OpenAlex:https://openalex.org/W4389613524

National Institutes of Health

Grant: 5R01AI158160-03

LASER ART for PreP

National Institutes of Health

Grant: 5R21MH128123-02

CNS HIV Theranostics Based on Intrinsic CEST Contrasts of Antiretroviral Drugs

National Institutes of Health

Grant: 1R01AI145542-01A1

Prodrug Formulations Create Sustained Release Antiretrovirals

National Institutes of Health

Grant: 1R21HD106842-01A1

Functional mechanism underlying Dolutegravir (DTG)-associated developmental CNS abnormalities: Inhibition of matrix metalloproteinases activities

National Institutes of Health

Grant: 3P20GM130447-02S1

Cognitive Neuroscience of Development and Aging (CoNDA) Center Supplement

FWCI

1.92

Citation Percentile

0.9%

Citation Trend

2024

2025

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fphar.2023.1294579/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2023.1294579/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2023.1294579/full

journalhttps://doi.org/10.3389/fphar.2023.1294579

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38149054

Fields of Study

Pregnancy and Medication ImpactPregnancy and preeclampsia studiesHIV Research and Treatment0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

DolutegravirMedicinePharmacologyDrugFetusToxicityAdverse effectPotencyGestationPregnancyInternal medicineHuman immunodeficiency virus (HIV)Viral loadChemistryVirologyIn vitroBiologyneurodevelopmentHIV-1Therapeutics. PharmacologyRM1-950long-acting nanoformulations

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being